Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teele Kuusk

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Urologic Oncology|March 7, 2020
Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancerTeele Kuusk, Patricia Zondervan, Brunolf Lagerveld, et al.
European Urology|May 24, 2021
The European Association of Urology COVID Intermediate-priority Group is Poorly Predictive of Pathological High Risk Among Patients with Renal TumoursPranav Satish, Teele Kuusk, Nick Campain, et al.
European Urology Oncology|April 10, 2025
Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines PanelLorenzo Marconi, Teele Kuusk, Milan Hora, et al.
European Urology Open Science|January 13, 2022
Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data AssessmentAafke Meerveld-Eggink, Niels Graafland, Sofie Wilgenhof, et al.
European Urology|April 8, 2022
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with HaematuriaBhavan P Rai, José Luis Dominguez Escrig, Luís Vale, et al.
European Urology|February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell CarcinomaJens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology|December 13, 2022
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
EJNMMI Research|December 5, 2018
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumorsTeele Kuusk, Maarten L Donswijk, Renato A Valdés Olmos, et al.
European Urology|October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines PanelUmberto Capitanio, Jens Bedke, Laurence Albiges, et al.
The Journal of Urology|December 11, 2017
Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT ImagingTeele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Urologic Oncology|March 7, 2020
Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancerTeele Kuusk, Patricia Zondervan, Brunolf Lagerveld, et al.
European Urology|May 24, 2021
The European Association of Urology COVID Intermediate-priority Group is Poorly Predictive of Pathological High Risk Among Patients with Renal TumoursPranav Satish, Teele Kuusk, Nick Campain, et al.
European Urology Oncology|April 10, 2025
Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines PanelLorenzo Marconi, Teele Kuusk, Milan Hora, et al.
European Urology Open Science|January 13, 2022
Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data AssessmentAafke Meerveld-Eggink, Niels Graafland, Sofie Wilgenhof, et al.
European Urology|April 8, 2022
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with HaematuriaBhavan P Rai, José Luis Dominguez Escrig, Luís Vale, et al.
European Urology|February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell CarcinomaJens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology|December 13, 2022
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
EJNMMI Research|December 5, 2018
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumorsTeele Kuusk, Maarten L Donswijk, Renato A Valdés Olmos, et al.
European Urology|October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines PanelUmberto Capitanio, Jens Bedke, Laurence Albiges, et al.
The Journal of Urology|December 11, 2017
Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT ImagingTeele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
Pageof 6